-
1دورية أكاديمية
المؤلفون: Peter C Wigfield, Bart Heeg, Mario Ouwens
المصدر: Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2023)
مصطلحات موضوعية: area between curves, markov models, optimization, state transition model, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2042-6313
-
2دورية أكاديمية
المؤلفون: Bart Heeg, Andre Verhoek, Gabriel Tremblay, Ofir Harari, Mohsen Soltanifar, Haitao Chu, Satrajit Roychoudhury, Joseph C Cappelleri
المصدر: Journal of Comparative Effectiveness Research, Vol 12, Iss 3 (2023)
مصطلحات موضوعية: bayesian hierarchical modelling, immunotherapies, indirect treatment comparisons, mixture cure, network meta-analysis, oncology, survival extrapolation, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2042-6313
-
3دورية أكاديمية
المؤلفون: Philippe Moreau, Cyrille Hulin, Sonja Zweegman, Mahmoud Hashim, Yannan Hu, Bart Heeg, Carla deBoer, Veronique Vanquickelberghe, Tobias Kampfenkel, Jianming He, Annette Lam, Sarah Cote, Pieter Sonneveld
المصدر: eJHaem, Vol 2, Iss 1, Pp 66-80 (2021)
مصطلحات موضوعية: clinical trials, monoclonal antibodies, multiple myeloma, thalidomide, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2688-6146
-
4دورية أكاديمية
المؤلفون: Lorenzo G. Mantovani, Patrizia Berto, Anna D. Ausilio, Bart Heeg
المصدر: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 5, Iss 1, Pp 5-11 (2004)
مصطلحات موضوعية: Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/782; https://doaj.org/toc/2240-256X
-
5
المؤلفون: Andre Verhoek, Parneet Cheema, Barbara Melosky, Benoit Samson, Frances A. Shepherd, Filippo de Marinis, Thomas John, Yi-Long Wu, Bart Heeg, Nadia Van Dalfsen, Benjamin Bracke, Miguel Miranda, Simon Shaw, Daniel Moldaver
المصدر: PharmacoEconomics - Open. 7:455-467
مصطلحات موضوعية: Pharmacology, Health Policy, Pharmacology (medical)
-
6
المؤلفون: Jianming He, Heather Berringer, Bart Heeg, Haoyao Ruan, Tobias Kampfenkel, Harikumaran R. Dwarakanathan, Stephen Johnston, João Mendes, Annette Lam, Sacheeta Bathija, Eric Mackay
المصدر: Advances in Therapy. 39:4230-4249
مصطلحات موضوعية: Bortezomib, Clinical Trials, Phase I as Topic, Clinical Trials, Phase III as Topic, Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humans, Standard of Care, Pharmacology (medical), General Medicine, Neoplasm Recurrence, Local, Multiple Myeloma, Dexamethasone, Thalidomide
-
7
المؤلفون: T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M Mamolo, Ana Gezin, Joseph C Cappelleri, Bart Heeg
المصدر: Future Oncology. 18:2029-2039
مصطلحات موضوعية: Leukemia, Myeloid, Acute, Cancer Research, Oncology, Cytarabine, Humans, General Medicine, Gemtuzumab
-
8
المؤلفون: Bart Heeg, Andrea Garcia, Sophie van Beekhuizen, Andre Verhoek, Ilse van Oostrum, Satrajit Roychoudhury, Joseph Christopher Cappelleri, Maarten Jacobus Postma, Mario Johannes Nicolaas Martinus Ouwens
المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE), Microbes in Health and Disease (MHD)
المصدر: Journal of Comparative Effectiveness Research, 11(15), 1121-1133. FUTURE MEDICINE LTD
مصطلحات موضوعية: DOCETAXEL, piecewise, MIXTURE, Health Policy, MODELS, MULTICENTER, decision framework, fractional polynomials, immunotherapies, OPEN-LABEL, indirect comparisons, CANCER, ATEZOLIZUMAB, oncology, survival extrapolation, splines, CROSS-VALIDATION, time-to-event end point, mixture modeling, network meta-analysis, parametric modeling
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84333b4e0163d9b38f370767f0d3d032
https://doi.org/10.2217/cer-2022-0044 -
9
المؤلفون: Bart Heeg, Ilse van Oostrum, Erik Buskens, Gianluca Baio, Maarten J. Postma, Antonio Remiro-Azócar, Mario Ouwens
المساهمون: Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD)
المصدر: Value in Health, 24(9), 1294-1301. ELSEVIER SCIENCE INC
مصطلحات موضوعية: Male, PREDNISONE, Technology Assessment, Biomedical, Cost effectiveness, Cost-Benefit Analysis, Population, Antineoplastic Agents, Medical Oncology, ECONOMIC-EVALUATION, Cross-validation, COST-EFFECTIVENESS, 03 medical and health sciences, 0302 clinical medicine, Statistics, Credible interval, Humans, LIFE EXPECTANCY, EVALUATE, 030212 general & internal medicine, Mortality, CROSS-VALIDATION, education, parametric modeling, Mathematics, Face validity, Parametric statistics, Aged, Aged, 80 and over, education.field_of_study, Likelihood Functions, general population mortality, 030503 health policy & services, Health Policy, additive hazards, Public Health, Environmental and Occupational Health, incremental life-years, Middle Aged, Survival Analysis, CANCER, RHEUMATOID-ARTHRITIS, Economic evaluation, Parametric model, MELPHALAN, Female, 0305 other medical science, FOLLOW-UP
وصف الملف: application/pdf
-
10
المؤلفون: Maarten J. Postma, Bart Heeg, Joseph C. Cappelleri, B. Muresan, Carla Mamolo
المساهمون: Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD)
المصدر: Applied Health Economics and Health Policy, 19(6), 929-940. Springer International Publishing AG
Applied Health Economics and Health Policyمصطلحات موضوعية: Adult, Oncology, Economics and Econometrics, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, NILOTINIB, ECONOMIC-EVALUATION, IMATINIB, Second line, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Nitriles, Humans, TOOL, Medicine, Original Research Article, Protein Kinase Inhibitors, health care economics and organizations, DASATINIB, Aniline Compounds, Adult patients, business.industry, Health Policy, Imatinib, General Medicine, Chronic phase chronic myeloid leukemia, Dasatinib, THRESHOLDS, Nilotinib, Imatinib Mesylate, Quinolines, Quality-Adjusted Life Years, ADJUSTED INDIRECT COMPARISONS, business, Bosutinib, medicine.drug
وصف الملف: application/pdf